Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis

TP53 is the most frequently mutated gene in human cancer. While no TP53-targeting drugs have been approved in the USA or Europe so far, preclinical and clinical studies are underway to investigate targeting of specific or all TP53 mutations, for example, by restoration of the functionality of mutate...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanovsky, Eva, Kluck, Klaus, Ourailidis, Iordanis, Menzel, Michael, Beck, Susanne, Ball, Markus, Kazdal, Daniel, Christopoulos, Petros, Schirmacher, Peter, Stiewe, Thorsten, Stenzinger, Albrecht, Budczies, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104808/
https://www.ncbi.nlm.nih.gov/pubmed/37059713
http://dx.doi.org/10.1038/s41420-023-01413-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104808/
https://www.ncbi.nlm.nih.gov/pubmed/37059713
http://dx.doi.org/10.1038/s41420-023-01413-1

Ejemplares similares